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Abstract 
The ever growing number of emerging micropollutants such as pharmaceuticals 
requests rapid and sensitive full-spectrum analytical techniques. Time-of-flight high-
resolution mass spectrometry (TOF-HRMS) is a promising alternative for the state-of-
the-art MS/MS instruments because of its ability to simultaneously screen towards a 
virtually unlimited list of suspect compounds and to perform target quantification. 
The challenge for such suspect screening is to develop a strategy which minimizes the 
false negative rate without restraining numerous false positives. At the same time, 
omitting laborious sample enrichment through large-volume injection ultra-
performance liquid chromatography (LVI-UPLC) is advantageous avoiding selective 
preconcentration.  
A novel suspect screening strategy was developed using LVI-UPLC-TOF-MS aiming 
the detection of 69 multi-class pharmaceuticals in surface water without the a priori 
availability of analytical standards. As a novel approach, the screening takes into 
account the signal intensity-dependent accurate mass error, hereby assuring the 
detection of 95% of pharmaceuticals present in surface water.  
Subsequently, the validation and applicability of the full-spectrum method for target 
quantification of the 69 pharmaceuticals in surface water is discussed. Analysis of 
five Belgian river water samples revealed the occurrence of 17 pharmaceuticals in a 
concentration range of 17 ng L-1 up to 3.1 µg L-1.  
Introduction 
Pharmaceuticals are emerging environmental micropollutants that receives increasing 
attention worldwide. Their continuous introduction into the environment, bio-
recalcitrance, and intrinsic ability to interfere with organisms concern the scientific 
community for their potential ecotoxic effects on the environment, toxicity towards 
humans, and the selection of antibiotic resistance in bacteria (Kümmerer et al., 2009; 
2010). No current legislative framework exists in the European context defining 
allowable concentrations for these potentially harmful pharmaceuticals in the 
environment. However, recently, the European Commission published a proposal 
concerning the review of the list of priority substances for the Water Framework 
Directive 2000/60/EC (Commission Decision, 2000) including a maximum annual 
average concentration of 100 ng L-1 for diclofenac in surface waters.  
The growing interest towards screening and quantification of this diverse group of 
pharmaceuticals in all kinds of environmental samples requests advanced multi-
residue analytical techniques. Full-spectrum high-resolution mass spectrometers 
(HRMS) such as magnetic sector, time-of-flight (TOF) and orbitrap instruments are 
therefore a promising alternative for the current state-of-the-art triple quadrupole 
(QqQ) MS/MS instruments. In MS/MS, typically a target analysis is performed on a 
predefined limited set of compounds of interest hereby depending on the availability 
of standards. In contrast, the full-spectrum HRMS approach has shown the potential 
to analyze and identify based on accurate mass a virtually unlimited number of 
analytes simultaneously and offers the ability for both suspect screening and target 
quantification (Chitescu et al., 2012; Díaz et al., 2011; Ibáñez et al., 2009; Krauss et 
al., 2010; K’oreje et al., 2012; Müller et al., 2011; Petrović et al. 2006). In suspect 
screening using full-spectrum HRMS instruments, there is no a priori need for 
analytical standards because the acquired chromatograms are searched for the exact 
ion masses of an unlimited list of suspect compounds within a certain mass tolerance. 
In a next stage, confirmation of the found suspects with analytical standards based on 
chromatographic retention time and/or fragment ions is possible and a target 
quantification can be performed through validation of only the limited set of 
confirmed compounds. 
Achieving quantification of trace amounts is a challenge in environmental analysis. 
Usually, samples must be preconcentrated and a clean-up of interfering matrix 
compounds is necessary to enhance the method’s performance limits using an 
enrichment step such as solid-phase extraction (SPE). These laborious sample 
preparations techniques can be omitted when applying large-volume injection (LVI, 
250 µL) instead of the traditional 5 to 20 µL injections. As an advantage, unwanted 
selectivity induced by the preconcentration step can be avoided using the LVI 
approach. 
Hence, we aimed to investigate and improve the potential of large-volume injection – 
ultra-performance liquid chromatography (LVI-UPLC) in combination with 
quadrupole time-of-flight (QTOF) HRMS for both rapid screening and target 
quantification of traces of pharmaceuticals. An optimized and validated novel and 
rapid analytical method for a broad variety of multi-class pharmaceuticals in surface 
water is presented, hereby aiming to screen and quantify traces down to a 
concentration of 100 ng L-1.  
To reach these goals, we investigated and optimized the determination of the accurate 
mass for qualitative analysis. Subsequently, the relationship between the mass error 
and the signal intensity was investigated allowing  the establishment of a signal 
intensity-dependent mass error tolerance and hereby keeping the false negative 
screening rate at 5%. Finally, the results of a suspect screening and validated target 
quantification study on five Belgian river water samples are presented. 
Methods 
Analytical standards 
Individual stock solutions of the 69 pharmaceuticals were prepared on a weight basis 
to a final concentration of 1 mg mL-1. Daily, a standard mix of the pharmaceuticals 
was prepared in deionized water, and subsequently serial diluted to a final 
concentration of 5, 1, 0.5, 0.1, 0.05 and 0.01 µg L-1 in deionized (i.e. analytical 
standards) and river water.  
Sampling and sample pretreatment 
Five river water samples were collected in prerinsed amber glass bottles on five 
different locations along the Maas and the Albert channel, Belgium, and stored at 4°C 
in the dark for no longer than 24 hours prior to analysis. Prior to standard addition, 
river water samples were filtered through 1.5 µm glass microfiber filters (934-AH, 
Whatman) and subsequently 0.1% and 0.02% (v/v) formic acid was added to all 
samples for analysis in electrospray positive and negative ion mode, respectively. 
Instrumental analysis 
The analysis were performed using an ultra-performance liquid chromatography 
(UPLC) system Waters Acquity (Waters, Milford, MA, USA) equipped with an 
autosampler with 250 µL loop for large-volume injection and coupled to a Xevo G2 
QTOF time-of-flight mass spectrometer with an orthogonal electrospray ionization 
(ESI) probe (Waters Corporation, Manchester, U.K.). Chromatographic separation 
was achieved with a UPLC Aquity HSS T3 150x2.1mm 1.8µm column (Waters, 
Milford, MA, USA). 
Briefly, for analysis in electrospray positive ion mode, the mobile phase used was (A) 
water/acetonitrile 98:2 (v/v) with 0.1% formic acid and (B) acetonitrile with 0.1% 
formic acid. In electrospray negative ion mode, the mobile phase used was (A) 
water/acetonitrile 98:2 (v/v) with 0.01% formic acid and (B) acetonitrile. The elution 
gradient for both modes increased linearly from 3 to 98% B in 11 min. Subsequently, 
initial conditions were recovered. The total time for the chromatographic analysis was 
19 min. The sample injection volume was 250 µL.  
The QTOF mass spectrometer was operated at a resolving power of 20,000 at Full 
Width at Half Maximum (FWHM) acquiring profile data over an m/z range of 50-
1200 Da. The data station operating software was Masslynx version 4.1 (Waters). 
Results and discussion 
Determination of the accurate mass for qualitative analysis 
A first challenge in the analytical data processing is the accurate and precise 
determination of the mass of a detected compound. Raw high-resolution MS data are 
profile data on which no post-processing is performed and where each scan in the 
chromatogram consists of a profile mass spectrum. The simplest methodology for the 
accurate mass determination reads the accurate mass directly from the raw profile 
data and takes the mass at the maximum intensity as the accurate mass. On the other 
hand, on post-processing the profile data by a centroiding algorithm, sticks replace the 
peaks of the profile mass spectrum and the mass attributed to each stick is the 
centroid. The result is thus a spectrum with sticks where the resolution of the 
spectrum peaks is eliminated. The question is how good such centroid algorithms are 
for finding the center of a mass spectrum peak in terms of mass accuracy and 
precision. 
To compare and evaluate the performance of both methodologies, the correctness of 
the accurate mass extracted from the profile data is compared to that obtained after 
centroiding the spectra using the Automated Peak Detection (APD) algorithm in the 
Masslynx software. Therefore, spectra extracted from an assay with deionized water 
spiked with a set of 17 compounds at a concentration of 5 µg L-1 are used (mass range 
between 152 and 916 Da). For each compound, 5 scans were selected between the 
chromatographic peak apex and the peak tail in order to cover a wide range of signal 
intensities. The variability on the mass accuracy clearly improved for the APD 
centroiding algorithm compared to the profile data approach. A significant decline of 
the standard deviation by a factor of 2.3 (two-sided F-test, p < 0.05) was observed. 
Therefore, for qualitative analysis a better estimate of the accurate mass of a spectrum 
peak can be obtained after centroiding the profile data. 
Development of an improved suspect screening strategy 
For screening, extracted ion chromatograms are constructed utilizing an optimized 
mass window width of 50 ppm (Vergeynst et al., 2013) and the APD algorithm was 
used to determine the accurate mass of found peaks. 
When screening a sample towards a list of suspect compounds, the error on the 
accurate mass must fall within certain boundaries (mass error tolerance) in order to 
restrain the detected compound as being the suspect one. In order to determine how 
wide this mass error tolerance should be when accepting a false-negative screening 
rate of 5%, a river water sample spiked with analytical standards of a sub-selection of 
44 pharmaceuticals (data not shown) to 0.01, 0.05, 0.1, 0.5, 1 and 5 µg L-1 was 
analysed, resulting in a training dataset of 208 observations. 
The variability of the accurate mass error showed to strongly decrease with increasing 
signal intensity (Figure 1). The multiplication of the mass error (ME) and the log-
transformed signal intensities (i) of the training data is independent of the signal 
intensity and uniformly distributed. Hence, the variability of the mass error was 
modelled as:  ∙ log	(	)~(0, ).  
This model permitted to draw the 95% confidence limits of the mass error as a 
function of the signal intensity (Figure 1). By screening an unknown sample, a 
smaller mass error tolerance will be applied for the positive conclusion of peaks with 
higher signal intensities or, in other words, the observations should fall within the 
95% confidence limits in Figure 1 to be restrained. 
 Figure 1. The variability of the mass error decreased inversely with the log-
transformed signal intensity. The training dataset was used for the calculation of the 
95% confidence limits. 
Suspect screening and target quantification of multi-class pharmaceutical 
residues in Belgian river water 
The applicability and performance of the developed optimized signal-intensity based 
suspect screening strategy was investigated by the analysis of five river water 
samples. By subsequent analysis of analytical standards of the suspect compounds, 
restrained peaks were confirmed when their retention time deviates not more than 
1.96 x standard deviation, i.e. within the 95% confidence interval, from the retention 
time of the respective analytical standard.  
In order to estimate both false negative and false positive screening rates, all found 
peaks in the surface water samples within a wider mass error tolerance of ±25 ppm 
are considered in a first step. The peaks restrained by the suspect screening (157 hits 
related to 37 different suspect compounds) fall within the 95% confidence limits. The 
signal intensity based screening showed a good performance with a false negative rate 
(i.e. peaks not-restrained by the suspect screening but confirmed by retention time) of 
4.6%. Seven out of the 37 restrained suspect compounds were not confirmed by 
retention time, resulting in a false positive rate of 10.1% (i.e. fraction of the 69 
suspect compounds restrained but not confirmed by retention time). 
The screening strategy thus revealed that in the 5 river water samples, 30 out of the 69 
suspect pharmaceutical compounds were restrained and confirmed in at least one 
sample. Subsequent target quantification and full method validation revealed a 
concentration range from 17 ng L-1 to 3.3 µg L-1 in the analysed river water (data not 
shown). For 5 compounds (atenolol, caffeine, ibuprofen, roxithromycin and sotalol) 
the concentration range exceeded the level of 100 ng L-1 at least once. Wille et al. 
(2010) detected and quantified 8 pharmaceuticals in seawater (1 - 855 ng L-1) and 
marine organisms from the Belgian coastal zone. To our knowledge, the results 
obtained in this study are the first validated ones for pharmaceuticals in Belgian fresh 
river waters.  
Advantages of the novel screening-to-quantification approach 
An important advantage of the developed suspect screening strategy is that there is no 
a priori need for analytical standards. For confirmation of the suspect screening 
results, only analytical standards of the restrained compounds are necessary and if the 
aim is also quantification, the validation of only the restrained and confirmed 
compounds is sufficient for a reliable quantification. Considering the 5 surface water 
samples focused in this study, mass traces related to 37 different suspect compounds 
were restrained in the chromatograms. Analyzing only these 37 compounds as 
analytical standards allows the confirmation based on the retention time, which was 
the case for 30 out of the 37 compounds. As a consequence, less analytical standards 
(37 instead of 69) are necessary and the workload for the full method validation can 
be reduced (30 instead of 69). 
Large-volume injection showed to be a second important advantage of the presented 
rapid analytical screening and quantification technique. The chromatography takes 19 
min and the analytical method requires no sample pretreatment (except for filtering 
the sample). This is in contrast with most published analytical methods for the 
analysis of micropollutants in surface water applying laborious and time-consuming 
SPE enrichment steps. Besides, sample enrichment techniques such as SPE 
preconcentrate compounds selectively and, as highlighted by Chitescu et al. (2012), 
achieving acceptable recoveries for all compounds is unlikely in multi-residue 
applications. 
Further research and optimization of LVI in combination with the newest-generation 
and more sensitive full-spectrum HRMS is encouraged for suspect screening and 
quantification of micropollutants in surface water aiming at least a performance limit 
of 100 ng L-1.  
Conclusion 
An innovative analytical method for screening and quantification of a set of 69 
pharmaceutical compounds in river water based on LVI-UPLC coupled to a 
quadrupole time-of-flight (QTOF) MS was developed and validated.  
A novel suspect screening strategy was established, assuring a false negative rate of 
5% by modelling the variability of the signal intensity-dependent accurate mass error. 
A first screening of five Belgian river water samples revealed the occurrence of 30 
out of 69 suspect pharmaceuticals (antibiotics, analgesics, antidepressants, alkylating 
agents, anti-inflammatories, etc.). The validated target quantification confirmed the 
presence of the pharmaceuticals in a concentration range of 17 ng/L up to 3.3 µg/L.  
The novel screening-to-quantification approach allows screening without the a priori 
availability of analytical standards. The applicability of this approach has been 
established as 30 out of the 37 compounds that were restrained by the screening 
strategy could be confirmed. As a consequence, less analytical standards (37 instead 
of 69) are necessary and the workload for the validation can be reduced (30 instead of 
69). 
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